Showing results (2271-2280 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|September 4, 2012
Umbilical cord blood graft enhancement strategies: has the time come to move these into the clinic?M Norkin, H M Lazarus, J R Wingard
Bone Marrow Transplantation|September 4, 2012
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centersM Stern, J R Passweg, S Meyer-Monard, et al.
Bone Marrow Transplantation|September 4, 2012
Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCTS Gerull, M Stern, A Ben Aissa, et al.
Bone Marrow Transplantation|July 10, 2012
Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patientsM Foglietta, S S Neelapu, L W Kwak, et al.
Bone Marrow Transplantation|July 10, 2012
Incidence and risk factors of EBV reactivation after unrelated cord blood transplantation: a Eurocord and Société Française de Greffe de Moelle-Therapie Cellulaire collaborative studyP Y Dumas, A Ruggeri, M Robin, et al.
Bone Marrow Transplantation|July 10, 2012
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)J P Halter, S M van Walraven, N Worel, et al.
Bone Marrow Transplantation|June 27, 2012
Long-term follow-up of informal caregivers after allo-SCT: a systematic reviewE M Wulff-Burchfield, M Jagasia, B N Savani
Bone Marrow Transplantation|June 27, 2012
Renal allografts in plasma cell myeloma hematopoietic cell graft recipients: on the verge of an explosion?L Nayak, H M Lazarus
Bone Marrow Transplantation|July 25, 1998
Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimenT Matsuyama, S Kojima, K Kato
Bone Marrow Transplantation|July 25, 1998
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myelomaM Cavo, G Bandini, M Benni, et al.
Pageof 993